147 related articles for article (PubMed ID: 34724019)
1. Screening for cerebral amyloid angiopathy based on serological biomarkers analysis using a dielectrophoretic force-driven biosensor platform.
Kim HJ; Park D; Yun G; Kim H; Kim HG; Lee KM; Hong IK; Park KC; Lee JS; Hwang KS
Lab Chip; 2021 Nov; 21(23):4557-4565. PubMed ID: 34724019
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
3. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
J Neurochem; 2024 Feb; ():. PubMed ID: 38362804
[TBL] [Abstract][Full Text] [Related]
4. [
Bergeret S; Queneau M; Rodallec M; Curis E; Dumurgier J; Hugon J; Paquet C; Farid K; Baron JC
Eur J Neurol; 2021 May; 28(5):1511-1519. PubMed ID: 33460498
[TBL] [Abstract][Full Text] [Related]
5. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
[TBL] [Abstract][Full Text] [Related]
7. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
Piccarducci R; Caselli MC; Zappelli E; Ulivi L; Daniele S; Siciliano G; Ceravolo R; Mancuso M; Baldacci F; Martini C
J Alzheimers Dis; 2022; 89(3):1039-1049. PubMed ID: 35964181
[TBL] [Abstract][Full Text] [Related]
8. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
11. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation.
Chatterjee P; Tegg M; Pedrini S; Fagan AM; Xiong C; Singh AK; Taddei K; Gardener S; Masters CL; Schofield PR; Multhaup G; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; van Buchem MA; Stoops E; Vanderstichele H; Teunissen CE; Hankey GJ; Wermer MJH; Sohrabi HR; Martins RN; The Dominantly Inherited Alzheimer Network
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805778
[TBL] [Abstract][Full Text] [Related]
12. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.
Renard D; Castelnovo G; Wacongne A; Le Floch A; Thouvenot E; Mas J; Gabelle A; Labauge P; Lehmann S
J Neurol; 2012 Nov; 259(11):2429-33. PubMed ID: 22576334
[TBL] [Abstract][Full Text] [Related]
13. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update.
Farid K; Charidimou A; Baron JC
Neuroimage Clin; 2017; 15():247-263. PubMed ID: 28560150
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
15. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
[TBL] [Abstract][Full Text] [Related]
16. Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.
Muir RT; Ismail Z; Black SE; Smith EE
Alzheimers Dement; 2024 Feb; 20(2):1436-1458. PubMed ID: 37908054
[TBL] [Abstract][Full Text] [Related]
17. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
[TBL] [Abstract][Full Text] [Related]
18. Pin1, endothelial nitric oxide synthase, and amyloid-β form a feedback signaling loop involved in the pathogenesis of Alzheimer's disease, hypertension, and cerebral amyloid angiopathy.
Wang JZ; Zhu WD; Xu ZX; Du WT; Zhang HY; Sun XW; Wang XH
Med Hypotheses; 2014 Feb; 82(2):145-50. PubMed ID: 24332564
[TBL] [Abstract][Full Text] [Related]
19. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.
Charidimou A; Farid K; Tsai HH; Tsai LK; Yen RF; Baron JC
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):410-417. PubMed ID: 29070646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
